Skip to main content
logo
Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · Real-Time Price · USD
4.670
-0.060 (-1.27%)
At close: May 29, 2026, 4:00 PM EDT
4.778
+0.107 (2.30%)
After-hours: May 29, 2026, 7:11 PM EDT

Atea Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
-----351.37
Revenue Growth (YoY)
-----622.49%
Gross Profit
-----351.37
Selling, General & Admin
30.2832.8648.8549.9248.7145.79
Research & Development
159.57148.02144.1114.2481.94167.21
Total Operating Expenses
189.85180.89192.95164.16130.65212.99
Operating Income
-189.85-180.89-192.95-164.16-130.65138.38
Interest Income
14.0216.3825.4929.2211.150.21
Total Non-Operating Income (Expense)
14.0216.3825.4929.2211.150.21
Pretax Income
-175.83-164.51-167.46-134.94-119.5138.59
Provision for Income Taxes
-6.32-6.160.931.02-3.5917.4
Net Income
-169.52-158.35-168.39-135.96-115.91121.19
Net Income to Common
-169.52-158.35-168.39-135.96-115.91121.19
Shares Outstanding (Basic)
808184838383
Shares Outstanding (Diluted)
808184838388
Shares Change (YoY)
-5.37%-3.29%1.05%0.17%-5.67%308.70%
EPS (Basic)
-2.11-1.94-2.00-1.63-1.391.46
EPS (Diluted)
-2.11-1.94-2.00-1.63-1.391.37
Shares Outstanding
80.0378.1384.4683.4483.2983.1
Free Cash Flow
-147.86-132.03-135.5-85.4-122.93-87.01
Free Cash Flow Per Share
-1.85-1.62-1.61-1.02-1.48-0.99
Gross Margin
-----100.00%
Operating Margin
-----39.38%
Profit Margin
-----34.49%
FCF Margin
------24.76%
EBITDA
-189.44-180.47-192.53-163.75-130.39138.41
EBITDA Margin
-----39.39%
EBIT
-189.85-180.89-192.95-164.16-130.65138.38
EBIT Margin
-----39.38%
Effective Tax Rate
3.59%3.75%-0.55%-0.75%3.00%12.55%
SEC Filings: 10-K · 10-Q